PEDIA-DOSE
Dead / Cancelled — Cancelled — Section 8 (as of 26 May 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85530278
- Registration number
- 4243572
- Mark type
- Stylized text
- Filed
- 31 Jan 2012
- Published for opposition
- 15 May 2012
- Registered
- 13 Nov 2012
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Antibacterial pharmaceuticals; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of pediatric otitis, external otic inflammation, conjunctivitis, keratitis, rhinitis, allergy, nausea, diarrhea, croup, malaise, cough, cold, upset stomach, fever, gas, acidity, constipation, itching, dermatitis, jaundice, mumps, and acne; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Pharmaceuticals, namely, anti-infectives; Potassium preparations for pharmaceutical purposes
Owner
- Asepsis Pharmaceuticals Inc., Sarasota, FL, US
- Asepsis Pharmaceuticals Inc., Sarasota, FL, US
- Asepsis Pharmaceuticals Inc., Sarasota, FL, US
Prosecution history
- 26 May 2023 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 13 Nov 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Oct 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 30 Oct 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 30 Oct 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Oct 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Oct 2018 — TEAS SECTION 8 RECEIVED
- 30 Apr 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Nov 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Nov 2012 — REGISTERED-PRINCIPAL REGISTER
- 12 Oct 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Oct 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 09 Oct 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Oct 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Oct 2012 — USE AMENDMENT FILED